CAT vs MDGL · P/E 48, rev $20.54B vs rev $180.1M
Caterpillar Inc (CAT) versus Madrigal Pharmaceuticals Inc (MDGL) — a side-by-side from cached financials, not a winner call.
Caterpillar Inc (CAT) is a farm & heavy construction machinery company listed on NYSE. It is led by Jim Umpleby.
Madrigal Pharmaceuticals Inc (MDGL) is a biotechnology company listed on NASDAQ.
Latest reported CAT revenue for 2026-06-30 was $20.54B. Net income was $3.59B. Revenue was up 18.0% from 2026-03-31 to 2026-06-30. CAT currently screens at market cap $440.29B and trailing P/E 47.7.
Latest reported MDGL revenue for 2024-12-31 was $180.1M. Net income was -$465.9M. MDGL currently screens at market cap $11.56B.
CAT currently screens at market cap $440.29B and trailing P/E 47.7. MDGL currently screens at market cap $11.56B.
Not investment advice. Open the CAT and MDGL stock pages for the full models.
Not investment advice.